In the present work, 79 structurally unrelated analytes were taken into account and their 19 chromatographic retention coefficients, measured by Immobilized Artificial Membrane Liquid 20
INTRODUCTION 33 34
Pharmaceutical drug development is still a highly inefficient process: over one third of the failures 35 in drug candidate development is estimated to occur due to unsatisfactory pharmacokinetic 36 properties 1 , mainly regarding absorption, metabolism and toxicity and the attrition rates for Central 37
Nervous System (CNS) active drugs are even higher 2 . In fact, before reaching the blood circulation, 38 a drug diffuses through the biological barriers separating the circulating blood from the interstitial 39 fluid that surrounds the tissues. For orally administered drugs, this barrier is the intestinal 40 epithelium whereas the passage of drugs designed to act at the CNS level is further regulated by the 41 Blood-Brain Barrier (BBB). The BBB is one of the most complex and extensively studied 42 biological barriers, and its function is to preserve mammalian brain integrity against possible 43 injurious substances. It is made of endothelial cells, narrowly adherent one to the other to form tight 44 junctions, restricting the passage of solutes 3,4 . Indeed, drug transport is strongly limited by this 45 peculiar biological structure to pure passive transcellular diffusion. In fact, the paracellular route, 46
i.e. the passage of actives through the gaps between each endothelial cell, is completely hindered. 47
Apart from active transport mechanisms, whose occurrence is difficult to predict on a solely 48 chemical structure basis, drugs can therefore cross the BBB only by the passive transcellular route. 49
Plenty of in vivo, ex vivo, and in vitro methods are available for measuring BBB partitioning of 50 analytes. Historically, one of the most used and reputed method is the determination of log BB 51 values 5 . Log BB is defined as: 52 53 log BB = log in which C Brain is the concentration that the analyte realizes in the brain tissues, and C Blood is the 56 concentration that it realizes in the blood. However, this method involves the use of animal models, based on the addition of surfactants to an aqueous mobile phase at concentrations higher than their 84 critical micelle concentrations (CMC) 17 resulting in the formation of micelles acting as a partition 85 phase. Both IAM and MLC chromatographic indexes, mainly if combined with in silico calculated 86 descriptors, have demonstrated effectiveness in the prediction of BBB drug penetration 16 . However, 87 the methods proposed are still too time-consuming to meet the demands of pharmaceutical 88 companies and their suitability should be confirmed on larger set of analytes. 89
The aim of the present work has been the development of drug BBB penetration oriented statistical 90 models based on analytical indexes, achieved on biomimetic conditions by medium/high-91
throughput methods, along with in silico calculated descriptors. To the best of our knowledge, this 92 is the study based on the highest number of compounds among those employing IAM and MLC 93 data to predict drug pharmacokinetic properties. 94 Therefore, particular attention is set on: 95 i) the setup of medium/high-throughput methods for the achievement of both IAM and MLC 96 indexes; 97
ii) the validation of such parameters by developing statistical models for the prediction of BBB 98 penetration (log BB) by using the chromatographic indexes along with in silico calculated 99 descriptors; 100 iii) the elucidation of the molecular mechanism involved in BBB passive diffusion of drugs; 101 MLC indexes were used to develop BBB passage potential predicting models along with either 168 static or conformational properties. At first, all the analytes were assumed as having zero atomic 169 charges, even the ones supporting one or more ionizable functions. The equations along with the 170 statistical validation are reported in Table 3 . In the equations thereby reported, r 2 is the multiple 171 regression coefficient, q 2 is the r 2 validated by Leave-One-Out (LOO) optimization, SE is the error 172 omeprazole (page S-6). This approach was adapted to mirror more closely what actually occurs in 201 vivo. Performing the weighted average of the properties benefited noticeably the relationships as 202 described by equations (5) and (6). It is also interesting to note how, according to the above 203 reported relationships, the BBB penetration of drugs will be enhanced for highly retained 204 compounds in MLC, how it is hindered by the occurrence of drug/membrane polar (Psa)/ 205 electrostatic (Dipole) interactions, and how the transport through the barrier seems favored for 206 bases (Charge). However, by taking into account the analytes assumed as static, the properties are 207 derived considering them in their minimum energy conformations, i.e. after minimization. Indeed, 208 several authors 29 reported that such conformations are not always the ones actually involved in 209 membrane barrier passage. Therefore, a conformational analysis in vacuum was carried out for each 210 analyte included in the data set by using the Boltzmann Jump method that generates at random 1000 211 possible conformations by exploring the conformational space of the rotatable dihedral angles. The 212 conformational analysis was first performed on the analytes assumed as having zero atomic 213 charges, then on the analytes assumed as completely charged and finally taking into account a 214 weighted average of the properties at the experimental pH 7.4, according to the pKa of each analyte. 215
In the following models the conformational properties were considered separately to look into the 216 predictive strength of the models. As it is evident from Table 3 , the use of conformational 217
properties instead of the static ones slightly worsened the relationships. This aspect is quite 218 interesting as the calculation of conformational properties can be rather time-consuming especially 219 if the compound libraries to screen are wide and the computers employed are not sufficiently 220 powerful. Conversely, the static properties are much faster to calculate. Performing the weighted 221 average of the conformational properties yielded the most predictive models (equations (11) and 222 (12)) and in those relationships, verapamil again behaved as an outlier, suggesting that such models 223 would not be able to mirror the penetration of analytes undergoing some sort of active transport, in 224 this case P-gp mediated efflux. It is interesting to point out how, among the ionized properties 225 employed for the statistical method development (equations (9) and (10) 
IAM INDEXES IN LOG BB PREDICTION 235
The same approach was extended to the IAM indexes. The equations along with the statistical 236 validation coefficient are reported in Table 4 . Indeed, taking into account either the properties of the 237 analytes assumed as having zero atomic charges (equations (13) and (14)) or those of the analytes 238 assumed as completely charged (equations (15) and (16)) resulted in a BBB passage predictive 239 strength inferior to that obtained by using MLC indexes. Such conclusions are supported by the 240 lower correlation coefficients obtained. It is interesting to note how domperidone, the compound 241 excluded in first best optimized model described by equation (14), is a well-known substrate of the 242 P-gp 26 , and is pumped out of cells by such efflux system despite its high biomembrane passive 243 diffusion. Analogously to what was observed in the analysis of MLC indexes, performing the 244 weighted average of the static properties resulted the winning strategy also for this set of 245 experimental measures. In fact, a 0.72 r 2 (n-1), achieved on a set as large as 79 analytes, employing 246 only four descriptors suggests that the model (equations (17) and (18)) is robust and reliable 247
However, these relationships are roughly comparable to those obtained by using MLC indexes 248 (equations (5) and (6)). This evidence is indeed rather surprising, since the IAM stationary phase 249 consists of analogues of phosphatidylcholine, the most abundant phospholipid expressed in the 250 capillary endothelium acting as a barrier between the blood and the cerebrospinal fluids (CSF), and 251 thus they would represent an ideal biomimetic system. Conversely, this kind of SDS based MLC 252 should have drawbacks arising from the different chemical structure of SDS in comparison with 253 membrane phospholipids. But this evidence would suggest that they are incidentally able to mirror 254 the drug/membrane interactions involved in vivo thanks to the peculiar amphiphilic features of the 255 anionic micelles. In fact, for some reasons, they seem to be able to model the passive BBB 256 penetration of drugs fairly better than IAM indexes. Furthermore, the physico-chemical descriptors 257 reported in equation (18) are the same as the ones in equation (6), supporting again the concept 258 according to which the polar (Psa) /electrostatic (Dipole) interaction component plays a relevant 259 role in hindering the BBB penetration of drugs. Again, bases seem to be favored in BBB entering 260 and this is also consistent with the clinical experience. In fact, polar and extensively protonated at 261 pH 7.4 basic compounds, such as amphetamine and methamphetamine, are known to have an 262 appreciable CNS activity but it is much harder to recall similar cases for polar acids. The 263 conformational analyses of the analytes neither assumed as having zero atomic charges, nor as 264 ionized benefitted the relationships. Moreover, even performing the weighted average was not 265 beneficial at all for the relationships (data not shown). 266 
IAM + MLC INDEXES IN LOG BB PREDICTION 272
In the present study, MLC and IAM indexes were, in a first instance, considered separately. 273
However, the evident differences in the elution order observed depict a rather different selectivity 274 between both techniques. For this reason, the development of the BBB entering potential statistical 275 models was also performed by considering both the chromatographic indexes at the same time, 276 along with three other molecular descriptors (five independent variables in total), starting from the 277 weighted average of the molecular properties. This strategy resulted in a markedly improved 278 predictive strength (equations (19) and (20)) as reported in Table 5 . These relationships may 279 suggest that the molecular mechanism involved in IAM-LC and MLC are different but play both a 280 relevant role in BBB diffusion of drugs. 281
P-GP AFFINITIES IN LOG BB PREDICTION 282
As already mentioned, each analyte present in the dataset was docked into each discrete binding site 283 on the P-gp and the binding affinities were incorporated in the development of BBB passage 284 predictive statistical models. Indeed, recent fuctional studies have identified seven sometimes 285 overlapping binding sites accommodating substrates and inhibitors in the greasy, polyspecific 286 binding cavity of P-gp. These binding sites were demonstrated able to allosterically communicate in 287 a negative heterotropic manner. Moreover, an additional binding site was recognized on the exterior 288 of P-gp bounded by residues from the transmembrane helices 9, 12 and the elbow helix 2. This site 289 faces away from the transporter, lying close to the predicted membrane-water interface and 290 intramembranous substrate-entry portal. 291
On average , highly clustered results were achieved, meaning that the conformational search 292 procedure was exhaustive enough to ensure a coverage of the accessible conformational space. An 293 extensive cluster analysis (RMSD tolerance was set to 2.0 Å) was performed and the binding 294 affinity now reported in Table 2A and Table 2B are the minimum and the most populated binding 295 energies of the clusters. The errors of the estimates of free energies of binding were never higher 296 than ± 1.8 kcal mol -1 . However, from the relationships reported above, P-gp affinities do not seem 297
to have an appreciable role in BBB passage. However, this is not entirely true because the statistical 298 model development was carried out using only four independent variables, thus leading the 299 software to select only the four most relevant descriptors, among which P-gp affinities were not 300 included. Indeed, when five independent variables were set in the statistical method development, 301 the P-gp binding affinities (Table 5A and 5B) were used by the software to build up the models. 302
Equations (21) and (22), generated by IAM indexes and four static properties of the analytes, 303 assumed as having zero atomic charges, is an example as can be seen in Table 5 . The AutoDock 304 GPF/DPF files for site 1 and 7, i.e. the ones actually involved in the statistical models (21) and (22), 305
are now provided as supplementary materials. 306 This is not surprising because among the considered analytes, the only ones known from the 307 literature to be substrates of P-gp are cimetidine, domperidone, ranitidine, rifampicin, quinidine and 308 verapamil 26 , and they represent less than 5% of the dataset. Indeed, the compounds considered were 309 selected in the attempt to mirror as accurately and completely as possible the marketed drugs, in 310 terms of diverse chemical nature, molecular volume, CNS activity and molecular lipophilicity. 311
Since the active transport comprises only for a minority of drugs, whereby the drug uptake in 312 mainly driven by passive transcellular diffusion, the limited predictivity of the P-gp molecular 313 affinity may be dataset related. This approach suffers from some limitations, the most evident one 314 being the aspect that the receptor flexibility is not taken into account. The main reason behind it is 315 the large number of degrees of freedom that should be considered in this kind of calculations, thus 316 requiring remarkable computational power. However, neglecting the receptor flexibility could lead 317 to poor docking results in terms of binding pose prediction in real-world settings. Therefore, these 318 results must be regarded as a preliminary attempt to gain new insights and model the active efflux 319 of drugs pumped out of cells by P-gp, being neither exhaustive nor complete. Other experiments 320 have to be performed and docking conditions further calibrated in order to validate the proposed 321 model. 322 In an attempt to further maximize the predictive strength of the models, IAM and MLC indexes 334 were used in combination with E-Dragon descriptors 30 . The E-Dragon software calculates more 335 than 1,600 descriptors, including not only the simplest atom type, functional group and fragment 336 counts, but also several topological and geometrical descriptors. The results and statistical method 337 validation are reported in Table 5 . Remarkably high correlation coefficients were achieved with 338 either IAM (r 2 = 0.78, equation (26)) or MLC (r 2 = 0.83, equation (24)). As suggested by the 339 similarly high q 2 values, those relationships are not affected by any over fitting. The plots of the 340 experimental vs predicted log BB values (as predicted by equation (24)) are reported in Figure 3 . Table 5 . While the former is a functional 346 group descriptor referring to the number of aliphatic carboxylic acids, the latter is a topological 347 descriptor, named distance/detour ring index of order 5. It is based on operation over the 348 distance/detour matrix D/∆, a square symmetric matrix that contains the ratios of the lengths of the 349 shortest to the longest path between any pair of vertices. It is calculated by the following equation: 350
351
Although the role that such a parameter could play in the BBB partition is unclear, being its 352 interpretation quite difficult, it cannot be excluded that it might affect the molecular flexibility of 353 the analytes. However, the models obtained starting from E-Dragon descriptors would again 354 support the view according to which the BBB penetration of drugs would be enhanced for highly 355 retained compounds either in IAM or MLC and hindered for compounds having greater PSA and 356 supporting one or even more acidic functions. To further validate the proposed method, the datasets 357 were divided randomly into 16 pairs of training and test sets. For each pair, the multiple linear 358 regression was performed and the equations derived from the training sets were subsequently used 359 to predict the log BB values of the test sets. Such value set was used to evaluate the regression 360 coefficient (r 2 ), the standard error (SE) of the estimates and the Fischer coefficients. The results of 361 this additional validation are shown in Table 6 . 362 363 
CONCLUSION 378 379
Highly significant (r 2 (n-1) up to 0.83) statistical methods for the BBB entering potential of drugs 380 were achieved by applying the proposed method, which incidentally shed new light into BBB 381 penetration of drugs. In fact, the BBB passage was found related to the analyte charges, being 382 hindered for compounds supporting one or more acidic functions, and enhanced for bases. 383
Moreover, molecules with higher dipolar momentum and greater PSA seemed less prone to cross 384 the BBB. The relatively high number of analytes taken into account support statistically the 385 suitability of the method as early screening method to evaluate BBB passage, and consolidate the 386 novelty of the present work. In the modeling of drugs' BBB passage, both IAM and MLC indexes 387 are found advantageously suitable; however, their combination with physico-chemical descriptors is 388 highly beneficial for prediction. From a theoretical point of view, it should be considered that both 389 IAM and MLC indexes relate to BBB passage data despite the different interactions they depict as 390 confirmed by the lack of co-linearity between those two analytical indexes. Again, their 391 simultaneous use in the statistic models, here performed for the first time, improved their prediction 392 strength, thus suggesting that both play a relevant role in BBB passage although mirroring different 393 phenomena. The P-gp efflux has also been investigated, but our results indicate that it would affect 394 the overall BBB drug uptake only negligibly. However, this conclusion should be regarded 395 cautiously due to the aspect that only a fewP-gp substrates were included in the set of analytes 396 considered. Furthermore, the molecular docking simulations suffer from several limitations, the 397 most important being the aspect that the receptor flexibility is not taken into account. This might 398 have played a role in the moderate predictivity of the in silico calculated P-gp binding affinities. 399
Finally, the proposed method is also suitable for pharmaceutical companies in the search for 400 accurate BBB penetration oriented screening methods as the chromatographic conditions were 401 carefully studied to obtain the indexes in a relatively short time such as to meet their demands. 402
Chromatographic indexes (MLC and IAM) were always included in the best statistical models; this 403 
